Wacker Biochem

Wacker Biotech is a leading contract development and manufacturing organization (CDMO) specializing in microbial production systems for the biopharmaceutical industry. As the life sciences division of the Wacker Chemie Group, the company provides comprehensive services ranging from molecular biology and analytical development to commercial-scale GMP manufacturing. Their proprietary ESETEC technology is a highly efficient E. coli secretion system that facilitates the production of complex proteins and antibody fragments. Wacker Biotech's capabilities extend to advanced therapies, including the production of messenger RNA (mRNA), plasmid DNA (pDNA), and live biotherapeutic products. With a global footprint including facilities in Germany, the Netherlands, and the United States, the company supports the development of vaccines and therapeutic proteins for a diverse range of clinical indications.